Literature DB >> 29728829

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Nikolaus Marx1, Heidi Noels2, Joachim Jankowski2, Jürgen Floege3, Danilo Fliser4, Michael Böhm5.   

Abstract

Patients with chronic kidney disease (CKD) exhibit a massively increased risk for cardiovascular (CV) events, and traditional strategies to improve CV outcome have largely failed in the context of CKD. This review article summarizes the current understanding of the pathophysiology of CVD in patients with CKD, defines the gaps in knowledge and describes the structure of the German Transregional Research Consortium SFB TRR219 which addresses "Mechanisms of Cardiovascular Complications in Chronic Kidney Disease".

Entities:  

Keywords:  Blood; CKD; Cardiovascular disease; Heart; Vessel

Mesh：

Year:  2018        PMID： 29728829     DOI： 10.1007/s00392-018-1260-0

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


  57 in total

1.  Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?

Authors:  Peter A McCullough
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

2.  Timing of sudden death relative to the hemodialysis procedure.

Authors:  Jeffrey Perl; Christopher T Chan
Journal:  Nat Clin Pract Nephrol       Date:  2006-12

Review 3.  Sudden cardiac death in chronic kidney disease: epidemiology and prevention.

Authors:  M Khaled Shamseddin; Patrick S Parfrey
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

Review 4.  The vulnerable patient with chronic kidney disease.

Authors:  Georg Schlieper; Katharina Hess; Jürgen Floege; Nikolaus Marx
Journal:  Nephrol Dial Transplant       Date:  2015-03-04       Impact factor: 5.992

5.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Authors:  A K Cheung; M J Sarnak; G Yan; J T Dwyer; R J Heyka; M V Rocco; B P Teehan; A S Levey
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

6.  Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.

Authors:  Dimitrios Farmakis; Panagiotis Simitsis; Vasiliki Bistola; Filippos Triposkiadis; Ignatios Ikonomidis; Spyridon Katsanos; George Bakosis; Erifili Hatziagelaki; John Lekakis; Alexandre Mebazaa; John Parissis
Journal:  Clin Res Cardiol       Date:  2016-12-20       Impact factor: 5.460

7.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 8.  Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease.

Authors:  Chris W McIntyre
Journal:  Blood Purif       Date:  2010-01-08       Impact factor: 2.614

9.  Arterial calcification in patients with chronic kidney disease.

Authors:  Nadezda Koleganova; Grzegorz Piecha; Eberhard Ritz; Peter Schirmacher; Annett Müller; Hans-Peter Meyer; Marie-Luise Gross
Journal:  Nephrol Dial Transplant       Date:  2009-03-27       Impact factor: 5.992

10.  Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden.

Authors:  Yrjö Leskinen; Terho Lehtimäki; Antti Loimaala; Visa Lautamatti; Timo Kallio; Heini Huhtala; Juha P Salenius; Heikki Saha
Journal:  Atherosclerosis       Date:  2003-12       Impact factor: 5.162
View more
  7 in total

Review 1.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

2.  [Cardiovascular pharmacotherapy and coronary revascularization in end-stage renal failure].

Authors:  L Lauder; S Ewen; I E Emrich; M Böhm; F Mahfoud
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

Review 3.  Hyperkalaemia in Heart Failure-Pathophysiology, Implications and Therapeutic Perspectives.

Authors:  Redi Llubani; Davor Vukadinović; Christian Werner; Nikolaus Marx; Stephen Zewinger; Michael Böhm
Journal:  Curr Heart Fail Rep       Date:  2018-12

4.  Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis.

Authors:  Christian Hemmers; Corinna Schulte; Julia Wollenhaupt; Dickson W L Wong; Eva Harlacher; Setareh Orth-Alampour; Barbara Mara Klinkhammer; Stephan H Schirmer; Michael Böhm; Nikolaus Marx; Thimoteus Speer; Peter Boor; Joachim Jankowski; Heidi Noels
Journal:  Biomedicines       Date:  2022-02-10

5.  One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry.

Authors:  Sean S Scholz; Lucas Lauder; Sebastian Ewen; Saarraaken Kulenthiran; Nikolaus Marx; Orazbek Sakhov; Floris Kauer; Adam Witkowski; Marco Vaglimigli; William Wijns; Bruno Scheller; Michael Böhm; Felix Mahfoud
Journal:  Clin Res Cardiol       Date:  2019-12-02       Impact factor: 5.460

Review 6.  Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities.

Authors:  Anika Himmelsbach; Carina Ciliox; Claudia Goettsch
Journal:  Toxins (Basel)       Date:  2020-03-14       Impact factor: 4.546

7.  Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease".

Authors:  Heidi Noels; Joachim Jankowski
Journal:  Toxins (Basel)       Date:  2020-06-11       Impact factor: 4.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.